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Abstract
Background: In areas where adult HIV prevalence has reached hyperendemic levels, many infants remain at risk of acquiring
HIV infection. Timely access to care and treatment for HIV-infected infants and young children remains an important
challenge. We explore the extent to which public sector roll-out has met the estimated need for paediatric treatment in a
rural South African setting.
Methods: Local facility and population-based data were used to compare the number of HIV infected children accessing
HAART before 2008, with estimates of those in need of treatment from a deterministic modeling approach. The impact of
programmatic improvements on estimated numbers of children in need of treatment was assessed in sensitivity analyses.
Findings: In the primary health care programme of HIV treatment 346 children ,16 years of age initiated HAART by 2008;
245(70.8%) were aged 10 years or younger, and only 2(,1%) under one year of age. Deterministic modeling predicted 2,561
HIV infected children aged 10 or younger to be alive within the area, of whom at least 521(20.3%) would have required
immediate treatment. Were extended PMTCT uptake to reach 100% coverage, the annual number of infected infants could
be reduced by 49.2%.
Conclusion: Despite progress in delivering decentralized HIV services to a rural sub-district in South Africa, substantial
unmet need for treatment remains. In a local setting, very few children were initiated on treatment under 1 year of age and
steps have now been taken to successfully improve early diagnosis and referral of infected infants.
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Introduction
Within the broader global HIV epidemic, paediatric HIV
infection remains a major cause for concern. UNAIDS estimates
that although only accounting for approximately 6% of all HIV
infected individuals, children under 16 years of age account for
12% of new infections and 13% of HIV related deaths [1]. The
relatively high proportion of deaths illustrates the need for timely
access to quality care and treatment [2], a need emphasized by
recent data on the benefits of early treatment in infants [3].
Nowhere are the challenges of preventing and treating
paediatric infection more acute than in South Africa, home to
more than one in seven of the world’s HIV infected population
[1], and where there is no evidence to date of substantial
reductions in the prevalence of HIV in antenatal clinics [4].
Mother-to-child transmission (MTCT) accounts for the large
majority of paediatric infections and PMTCT targets the peri-
partum period. We have previously estimated the number of
children likely to be eligible for treatment in South Africa up to
end of 2003 using a novel model [5]; of the 758,595 children
estimated to have acquired HIV infection between 1993–2003,
approximately half were predicted to be alive and ultimately in
need of HAART at the time of widespread treatment roll-out.
Although early treatment has been shown to reduce mortality in
vertically-infected infants [3], identification and early referral of
infected infants in the first weeks or months of life remains a
challenge in most settings. With the advent of antiretroviral roll-
out, HIV programme managers at a local level increasingly need
to make difficult decisions on how to allocate scarce resources to
best meet the needs of the population they serve [2]. Here we
apply the existing model to a well characterized rural sub-district
of KwaZulu-Natal using locally derived data to assess the number
of children expected to be alive and eligible for treatment on the
basis of clinically advanced disease and use the estimates to assess
the performance of a decentralized paediatric HIV service.
Methods
Hlabisa sub-district lies in northern KwaZulu-Natal within the
Umkhanyakude district which is one of the most deprived districts
within South Africa [6]. The area is largely rural. The sub-district
hosts a demographic surveillance site (DSS) in which detailed
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demographic, economic and health data on the local population
have been collected since 2000; the surveillance covers about half
of the population of the sub-district [7].
The Department of Health HIV Treatment and Care
programme in the Hlabisa sub-district first began treating patients
in late 2004. The programme is run in partnership with the Africa
Centre for Health and Population Studies, University of
KwaZulu-Natal (www.africacentre.com). This analysis addresses
the period from programme inception until 2008. Whilst initially
based in the district hospital, the service is now decentralised to a
community healthcare centre (CHC) and all primary health care
centres (PHCs) within the wider Hlabisa sub-district [8]. Paediatric
care in the local service was integrated with adult services at all
sites and care was provided by trained healthcare workers,
primarily counsellors and nurses with regular medical support.
Treatment was provided within South African government
guidelines which use a combination of clinical and CD4 criteria
for initiation of treatment [9].
PMTCT services in the area started in August 2001 at one clinic
and by August 2002 were rolled out to all primary health care
clinics in the sub-district[10]. Single dose nevirapine was provided
to mothers and infants, and infant feeding counselling provided.
After 2004, when the HIV treatment programme was established,
women with CD4 counts ,200 cells per ml were referred for
treatment for their own health. South African PMTCT guidelines
were revised in late 2007 to include zidovudine for HIV infected
pregnant women from 28 weeks gestation in line with WHO
recommendations [11] and implemented in April 2008.
Within the partnership, the Africa Centre is the custodian of a
database relating to patients enrolled in the HIV treatment
programme; the number of infected children in care within the
programme were provided through the routine monitoring and
evaluation process. Patients gave written informed consent on
enrollment. Ethics approval for use of programmatic data was
received from the Department of Health, Pietermaritzburg and
Biomedical Research Ethics Committee of the University of
KwaZulu-Natal.
A deterministic mathematical modeling approach was employed
to estimate the number of HIV infected children who should be
accessing HIV care and treatment within the sub-district. The design
of the model and the assumptions contained within it has been
described in detail previously [5]. Variables required for the model
were: population size, antenatal HIV prevalence, birth rate, uptake of
PMTCT services by pregnant women, proportion of mothers
breastfeeding during post partum period, median duration of breast
feeding, survival with and without HAART and the proportion of
HIV positive children taking up treatment. Data used for the model
are presented in Appendix S1; where available, local data for the time
period were used. The population of the sub-district was estimated
from census data at 212,000 and assumed to be constant throughout
the period in question. Birth rates for the period 2000 to 2007 were
computed using data from the Africa Centre Surveillance from the
registered annual births divided by the annual person years of
exposure. The number of births for 1999 and 1998 (before the start of
the Africa Centre surveillance) were obtained by reverse projecting
the population of children who were 1–2 year and 2–3 year old in
2000, respectively. To obtain the mid-year population, the total
population for 2000 was also reverse projected to 1999 and 1998.
Birth rates from the demographic surveillance population were
assumed to be representative of the wider sub-district. The median
duration of breastfeeding was assumed to be constant throughout the
study period at five months. Antenatal prevalence data were taken
from Department of Health estimates for Hlabisa sub-district [4] as
was uptake of single dose nevirapine (sdNVP) by HIV positive
mothers [6] and extrapolated forward assuming constant coverage
between 2004–7, consistent with local data. Data for breastfeeding
were estimated from a large local study of vertical transmission
[12,13]. HAART eligibility was based on clinical disease progression
[14] and the estimated number of children with moderate and severe
clinical disease (equivalent to WHO stage 3 or 4) in a particular age
group [5]. In the first year of life the total number of infants (ie those
aged under 1 year) with advanced clinical disease equates to the
estimated number progressing to severe disease; in later years the
estimated total number is a cumulation of those surviving from
previous years plus those developing severe disease in a given year,
after applying the age-category specific mortality rate [5]. As the
mortality rate in the first year of life is very high, and disease
progression very rapid, the disease progression andmortality rates are
applied on a monthly basis. Without rapid diagnostics, or treatment
on the basis of presumptive diagnosis, the majority of children who
progress to serious disease in their first year will not be diagnosed and
not access effective treatment before they die – consequently, very
small numbers of infants are estimated to be requiring treatment.
This effect remains throughout the cohort, although becomes less
pronounced with age.
Sensitivity analyses addressed varying assumptions relating to
PMTCT uptake and regimen, and timely diagnosis of infants born
to HIV infected mothers, with appropriate and rapid referral into
the treatment programme. We assume that the rate of PMTCT
uptake remains constant with 54% of women receiving sdNVP
(overall MTCT rate = 17.0%), we then examined the impact of
adding Zidovudine to the sdNVP, both at 54% and 100%
coverage (overall MTCT rates or 14.9% and 8.8% respectively).
We also explored the potential effect if women with a CD4 count
of 350 or less would be eligible for HAART by assuming a 50%
coverage of HAART initiated during pregnancy, with the
remaining women with a CD4 count above 350 cells receiving
sdNVP (overall MTCT =7.9%). Breastfeeding rates remained
unaltered for all the sensitivity analyses, although HAART is
assumed to lower the post-natal transmission rate.
Results
The estimated number of HIV exposed and infected children
born annually increased between 1997 and 2000 (Table 1), but
subsequently declined following a reduction in the birthrate [15],
Table 1. Estimated annual number of infants born to HIV
infected women (exposed) and numbers of infected and
uninfected infants.
Year Exposed infants Infants infected Infants uninfected
2007 1837 313 1,524
2006 2249 386 1,864
2005 2642 456 2,186
2004 2588 449 2,139
2003 2256 439 1,817
2002 2321 491 1,830
2001 2523 567 1,957
2000 2843 653 2,191
1999 2519 578 1,940
1998 2490 572 1,918
1997 2142 492 1,650
doi:10.1371/journal.pone.0007101.t001
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the introduction of PMTCT services, and changes in infant
feeding practices which would have reduced the risk of MTCT.
The estimated total number of surviving HIV-infected children
up to 10 years of age in 2007 was 2,561 (Table 2), of whom 521
would be in need of immediate antiretroviral treatment (ART)
under the model assumptions which relate to the treatment
guidelines during the period of study. Changing the model
assumption to all infants being diagnosed promptly (and thus some
receiving treatment earlier), the total number of children estimated
to be in need of treatment would rise to 576.
The number of infected children who would be estimated to be
alive declines slowly with age, with 334 predicted to survive to
their first birthday and 144 reaching their 10th birthday in 2007
(Table 2). The number of children predicted to be requiring
antiretroviral treatment varies by age: 207/1037 (19.9%) of
surviving HIV infected children aged 3 years or younger were
predicted to require treatment depending on whether an
immediate diagnosis of HIV was made or not; 115/731 (15.7%)
of surviving children aged 4–6 years and 190/795 (23.8%) of
surviving children 7–10 years of age. These variations are a
reflection of the local dynamics of the epidemic.
To address the issue of early diagnosis and treatment of
vertically-infected infants, we estimated the number of HIV
infected infants born each year, which shows a steady annual
decline (Table 1). If the uptake of the 2007 PMTCT regimen,
sdNVP, remained constant along with all variables, through the
following year, we would predict that 299 infected children would
be born to 1755 HIV positive mothers during 2008. If we further
allow for the addition of Zidovudine to the PMTCT regimen, as
per 2008 SA guidelines, the number of infected children would be
reduced to 262. Results from further sensitivity analyses show that
should it be possible to increase uptake of Zidovudine/sdNVP to
100%, an estimated 152 children would be infected – a reduction
of 49.2% from the 299 infected children predicted. Assuming that
pregnant women with a CD4 count of 350 cells per ml or less
would be eligible for HAART, with an associated reduction in the
rate of MTCT, would in 2008 reduce the number of infected
children to 138, a 62% reduction. These figures assume all other
variables to be constant.
From programme inception until the end of 2007, a total of 346
children under the age of 16 years were recorded as initiating
ART, 184/346 (53.1%) were male. The number of children
initiating treatment for the periods 2004/2005, 2006 and 2007
were 59, 103 and 184 respectively. A total of 245/346 initiated
treatment aged 10 or younger. Compared to the lowest estimated
figure of 521 needing treatment (assuming conservative initiation
criteria in place during the period of study), these figures suggest
two thirds of infants requiring HAART had initiated treatment.
Inclusion of infants less than one was rare, with only one in 2006
and one in 2007. However, in 2008 with the establishment of a
family clinic and improvements in the service, there were 41
infants less than one year of age initiated on treatment and these
results will be presented more fully in future work.
Discussion
Antiretroviral roll-out is maturing in South Africa and by the
end of 2007 national figures from South Africa estimated that
32,060 children under the age of 15 had been initiated on
treatment within the public sector [16]. One of the many
challenges faced by the health system is the high number of
children in need of antiretroviral treatment in areas of high HIV
prevalence and the demands in reaching all HIV positive mothers
with a package of care to prevent mother-to-child transmission.
The failure to meet the demand for care and treatment is part of
the reason that there has been little progress in achieving one of
the key Millenium Development Goals in sub-Saharan Africa,
namely reducing the mortality rate for children under five by two-
thirds by 2015 [17].
The ongoing scale of the epidemic poses enormous challenges
for programme managers trying to meet the need of their
populations with limited resources and for whom it is important to
have some estimate of the numbers of individuals who should be
accessing care within local settings [2]. Here we apply a model that
has been described previously [5] to a local population and find
that by the end of 2007 approximately two thirds of the number of
children predicted to need treatment had started HAART.
The numbers produced by this method of estimation should
only be considered an approximation of the reality on the ground.
The extent to which uptake of treatment in the local population as
a whole can be reliably established from the data shown here is
limited by a number of factors. The public sector service, whilst
the dominant provider in many settings, including the one
described here, is not alone in providing treatment; GPs, NGOs,
private practitioners/paediatricians and employers (for parents)
amongst others also contribute to meet the needs of the
population. As such, the figures for treatment uptake here are
likely to represent a lower estimate of the actual number of
individuals initiated on treatment in the local area, although the
evidence available suggests the use of private healthcare services in
the area is low [8].
In addition, the estimates of need in this population should be
considered conservative, with approximately 20% of infected
individuals predicted to be in need of treatment in this setting.
These estimates were based on guidelines in place at the time and
reflect need as defined by guidelines. Recent data emerging from
the CHER study on the benefits of early treatment [3] and
subsequent changes to South African paediatric treatment
guidelines [18], emphasize the well-recognised need to improve
timely access of children to care and treatment, particularly
through improved systems of early diagnosis [19,20]. What can be
seen from the local data is that compared to the proportion of
children estimated to be in need of treatment within each age
Table 2. Estimated number of surviving HIV infected children
requiring treatment by age, 2007 [5].
AGE (years)
Total number
estimated to
be alive
Estimated
number Alive
and MSD1 free
Estimated
number requiring
Treatment
1 334 285 49
2 388 300 88
3 315 245 70
4 250 207 42
5 239 202 37
6 242 198 44
7 258 200 57
8 207 158 49
9 186 140 46
10 144 106 38
2,561 2,040 521
1MSD = Infected children with moderate/severe disease who would meet
treatment eligibility criteria.
doi:10.1371/journal.pone.0007101.t002
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category, the number of children initiating treatment is broadly
similar across age ranges, except in those aged under one year
where there is a more dramatic short-fall. It is of interest to note
that through targeted efforts within the programme in the
identification and rapid referral of infected infants, the numbers
of infants under one year of age in the programme has drama-
tically increased during the latter half of 2008. Initiatives included
a one-day workshop for all HIV counsellors on paediatric
eligibility for ART and the importance of rapid referral of
HIV-infected infants; training to increase awareness amongst
nurses of the clinical symptoms and signs associated with HIV in
infancy; testing of all children admitted to hospital where consent
given; using opportunities presented during immunization and
vitamin A campaigns at primary health care facilities to check
health cards of all children to ensure their HIV status known. This
shows that substantial improvements can be made relatively
rapidly, where data and resources are available to inform
intervention. However, modelling of future treatment will need
to have greater focus on those under one year of age, particularly
with new WHO recommendations that all children under 1 year
of age should receive ART irrespective of their clinical or
immunological status [21].
Whether the figures for uptake within the local programme
here are indicative of ‘‘good’’ or ‘‘bad’’ performance is not a
straightforward, nor perhaps a very helpful question [22]. There
are very little data for comparison with other programmes in
different healthcare settings, though this methodology could be
applied elsewhere as one form of comparison. One could argue
that in a rural environment with limited healthcare resources
where care is largely delivered through a decentralized system of
primary healthcare clinics, that to achieve the levels of uptake seen
here is important progress. However, whilst currently manageable,
even these predicted numbers of HIV infected children require
substantial resources [2]. Even using our most conservative
estimate here of 152 infants born with HIV each year, if all were
diagnosed and treated in a timely manner, resources will soon be
stretched if there is no further change in adult HIV prevalence and
fertility rates.
As with all healthcare initiatives in resource poor settings,
attention has to be given to sustainability, quality of care and the
opportunity costs of prioritizing one area of care. The develop-
ment of paediatric care and treatment services will need to be
explicitly linked into broader prevention efforts including inter-
ventions targeting fertility and aimed at keeping HIV negative
individuals, particularly adolescents, negative. How this can best
be done needs to be a research priority. One such approach is to
identify ways in which the provision of family services, can provide
an avenue into the broader challenge of adult HIV transmission in
the wider population. Expanding HIV testing and encouraging all
to know their status are cornerstones of prevention efforts and,
engagement with paediatric services offers one route to encourage
other family members, particularly fathers, who might not be
aware of their HIV status to test, and if necessary enter care.
The data presented here show that despite expansion of services
and efforts towards early diagnosis and care for infected children,
there is still a significant unmet need for treatment in this setting,
even when services are available at primary care facilities. It is
possible through targeted efforts to rapidly improve access,
however this will continue to challenge limited healthcare
resources for the foreseeable future, particularly with greater
emphasis on early diagnosis and treatment in infants, and this
should further encourage prevention efforts both in mother to
child transmission and in the general population.
Supporting Information
Appendix S1 Percentage of women attending antenatal clinic
who test positive for HIV; estimates taken from South African
Dept of Health figures[4]. 2 Number of live births per 1,000
population; estimates from Africa Centre Surveillance data 3
Percentage of HIV infected pregnant women who receive either
no treatment or single-dose NVP to prevent MTCT; estimates
based on mothers and infants receiving treatment and taken from
South African Department of Health Estimates for 2003/4 [6] and
extrapolated forward assuming constant coverage 4 Percentage of
HIV infected mothers who a, never breastfed their infant, b,
breastfed their infant for ,6 months, or c, breastfed their infant
for more than 6 months; estimates extrapolated from local study of
infant feeding behaviours [12,13] 5 Percentage of HIV infected
children who have access to a, no treatment, or b, PCR testing, co-
trimoxazole prophylaxis and ART when required; estimates from
Africa Cente Surveillance data
Found at: doi:10.1371/journal.pone.0007101.s001 (0.04 MB
DOC)
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